– June 1, 2006
June 1, 2006
View Issues
-
Melphalan, Prednisone and Thalidomide: The Standard Approach for Myeloma in Elderly Patients?
Two thirds of cases of multiple myeloma are diagnosed after the age of 65 years. -
Arsenic and ATRA for APL Induction
Although highly sensitive to a variety of agents, the need for prolonged therapy, particularly with anthracyclines in APL patients, may lead to significant toxicity and be contraindicated in others. -
ZAP-70 and CD38: Markers of Importance in CLL
B-cell chronic lymphocytic leukemia (b-cll) is a disease with a highly variable clinical course. -
Results of Raloxifene RUTH and STAR Trials
Clinical trial results indicate that raloxifene has no effect on the risk of coronary heart disease and is equivalent to tamoxifen in reducing the risk of invasive breast cancer. -
Pharmacology Watch
The absorption of thyroxine is strongly influenced by stomach acidity, according to new study. -
Clinical Briefs in Primary Care Supplement